Perfil
Holger Lembrér is currently Chief Financial Officer at Enzymatica AB since 2026.
Formerly, Chief Financial Officer at Boule Diagnostics AB from 2024 to 2026, Chief Financial Officer at Oncopeptides AB in 2023, Chief Financial Officer at ASSA ABLOY.
AB from 2011 to 2019, and Auditor at Ernst & Young AB from 2008 to 2011.
Education includes a graduate degree from the University of Uppsala.
Últimas noticias acerca de Holger Lembrér
Cargos activos de Holger Lembrér
| Empresas | Cargo | Inicio |
|---|---|---|
| ENZYMATICA AB | Director Financiero/CFO | 13/04/2026 |
Antiguos cargos conocidos de Holger Lembrér.
| Empresas | Cargo | Fin |
|---|---|---|
| BOULE DIAGNOSTICS AB | Director Ejecutivo | 16/04/2024 |
| ONCOPEPTIDES AB | Director Financiero/CFO | 13/11/2023 |
| ASSA ABLOY AB | Director Financiero/CFO | 01/04/2019 |
Ernst & Young AB
Ernst & Young AB Miscellaneous Commercial ServicesCommercial Services Provides tax advisory and accounting services | Comptroller/Controller/Auditor | 01/09/2011 |
Formación de Holger Lembrér.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Assa Abloy AB
Assa Abloy AB Tools & HardwareConsumer Durables Manufactures and sells mechanical, electromechanical, digital door locks and smart home access solutions | Consumer Durables |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Boule Diagnostics AB
Boule Diagnostics AB Medical SpecialtiesHealth Technology Develops, manufactures, and markets medical tools | Health Technology |
Ernst & Young AB
Ernst & Young AB Miscellaneous Commercial ServicesCommercial Services Provides tax advisory and accounting services | Commercial Services |
Enzymatica AB
Enzymatica AB Medical SpecialtiesHealth Technology Develops and sells medical technology products against infectious diseases | Health Technology |
- Bolsa de valores
- Insiders
- Holger Lembrér
















